Succeed in Medicine: Practical Knowledge for Busy Physicians · Bradley B. Block, MD, Doctor Podcast Network

GLP-1 Agonists: Separating Fact from Fiction with Sean Wharton, MD, PharmD, Part 1| Ep501

·29 min·2 clips
Dr. Sean Wharton reveals why obesity is not just about BMI but a disease tied to visceral adiposity and health impairment.
Dr. Sean Wharton discusses GLP-1 agonists, explaining their history from diabetes treatment to weight loss, the concept of food noise, and redefining obesity as a disease. He addresses misconceptions and emphasizes compassionate patient communication in obesity management.

As heard by us

A grounded look at GLP-1 agonists, food noise, and why treatment may need to continue.

Dr. Sean Wharton keeps the conversation on GLP-1 agonists grounded in day-to-day medicine rather than hype. He is presented as an internal medicine physician, director of the Wharton Medical Clinic, and lead author of the 2020 Canadian Obesity Guidelines, and the discussion…

Read the full review in PlayNext →

Why you'd press play

You want a plainspoken read on GLP-1s before the next patient conversation.

Read the full recommendation in PlayNext →
Listen to the show on